A nurse is assessing a 45-year-old female client who has been experiencing joint pain, fatigue, and a butterfly-shaped rash across her cheeks and nose bridge for the past 3 months. Which assessment finding would be most significant in supporting a diagnosis of systemic lupus erythematosus (SLE)?

Positive ANA with homogeneous pattern is the most significant finding for SLE diagnosis, as it is present in over 95% of patients and is a key diagnostic criterion. Other options like elevated ESR, positive RF, or decreased complement levels are less specific or supportive but not definitive for SLE.

Understanding the Question

This question asks you to identify the most significant assessment finding for supporting a diagnosis of systemic lupus erythematosus (SLE) in a client presenting with classic symptoms. The client’s joint pain, fatigue, and malar (butterfly) rash are highly suggestive of SLE, and you must select the laboratory result that provides the most specific serological evidence.

Analysis of Each Option

1. Elevated erythrocyte sedimentation rate (ESR) of 65 mm/hr
An ESR of 65 mm/hr is a nonspecific indicator of inflammation. While it is frequently elevated in active SLE due to systemic inflammation and increased immunoglobulin production, it can also rise in infections, malignancies, and other rheumatic diseases. It does not provide specific support for an SLE diagnosis over other inflammatory conditions.

2. Positive rheumatoid factor (RF) test result
A positive rheumatoid factor (RF) is an autoantibody primarily associated with rheumatoid arthritis (RA), not SLE. While a patient could theoretically have an overlap syndrome like rhupus syndrome, which features both RA and SLE, this is a rare condition ^[1]. In a straightforward presentation of SLE, a positive RF is not a diagnostic criterion and would point more toward RA.

3. Decreased complement levels (C3 and C4)
Decreased complement levels (C3 and C4) are a very common finding in active SLE, reflecting immune complex-mediated consumption of the complement cascade. This finding correlates well with disease activity, especially in lupus nephritis ^[1]. However, it is a marker of disease activity and severity, not a primary diagnostic criterion. The diagnosis is initially established through clinical presentation and specific autoantibodies.

4. Positive antinuclear antibody (ANA) test with homogeneous pattern
A positive antinuclear antibody (ANA) test is the most significant finding for supporting an SLE diagnosis. The ANA test is the primary serological screening test for SLE, with a sensitivity of nearly 95%. A homogeneous staining pattern is particularly associated with antibodies to double-stranded DNA (dsDNA) or histones, which are central to the pathogenesis of SLE. The diagnostic criteria for SLE rely heavily on a positive ANA as an entry criterion, followed by clinical and immunological features. This directly aligns with the case report’s description that diagnosis of lupus is based on clinical features in conjunction with positive serologic lab results ^[1].

Why the Correct Answer is Superior

The key distinction is between a screening/diagnostic marker and a disease-activity marker. The ANA test is the foundational serologic test for establishing the diagnosis of SLE. While decreased complement levels support the diagnosis and indicate active immune complex formation, the positive ANA with an appropriate pattern is the most significant initial laboratory finding that, when combined with the classic malar rash and joint symptoms, solidifies the diagnostic picture for SLE.